论文部分内容阅读
目的探讨莫西沙星与左氧氟沙星在治疗老年社区获得性肺炎(CAP)疗效分析。方法选取本院2011年10月~2013年10月老年CAP患者200例,通过随机数表法将所有患者平均分成A1组(观察组)与A2组(对照组)。针对A1组与A2组患者,治疗的疗程定为10 d。针对A2组患者主要选择左氧氟沙星进行治疗,针对A1组患者主要选择莫西沙星进行治疗,对比两组患者完成治疗后分别获得的效果表现。结果 A1组优于A2组(P<0.05),两组副作用无明显差别。结论针对老年CAP患者,采用莫西沙星进行治疗,表现了显著的治疗效果,副作用并未增加。
Objective To investigate the efficacy of moxifloxacin and levofloxacin in the treatment of elderly community-acquired pneumonia (CAP). Methods 200 elderly CAP patients from October 2011 to October 2013 in our hospital were selected. All patients were equally divided into A1 group (observation group) and A2 group (control group) by random number table method. For A1 and A2 patients, the course of treatment for the treatment of 10 d. Levofloxacin was selected for the treatment of patients in group A2, and moxifloxacin was selected for the treatment of group A1. The effect of the two groups of patients after treatment was compared. Results A1 group was better than A2 group (P <0.05), no significant difference between the two groups. Conclusion For elderly patients with CAP, moxifloxacin treatment showed significant therapeutic effect, side effects did not increase.